Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISV-305 for inflammation and pain after cataract surgery
NCT03192137Phase 3Completed
- Sponsor
- Sun Pharma
- Start
- Jan 2018
- Primary completion
- Apr 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in ocular inflammation, sponsored by Sun Pharma. Started Jan 2018; status: completed.
02
Drugs
dexamethasone
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT03192137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03192137.